Lyophilization Services for Biopharmaceuticals Market to Reach $3.58Bn by 2028 with Lyophilization Cycle Development Segment Driving Growth During 2023–2028 | The Insight Partners

The Insight Partners published latest research report on "Lyophilization Services for Biopharmaceuticals Market Size Report, Share, Trends & Growth Forecast to 2028 - COVID-19 Impact and Global Analysis By Service Type, and End User”, the global market size is projected to reach USD 3,586.55 million by 2028 from USD 2,051.41 million in 2022. The market is estimated to grow with a CAGR of 9.9% from 2023 to 2028.

Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00009286

Global Lyophilization Services for Biopharmaceuticals Market: Competitive Landscape and Key Developments:

ATTWILL Medical Solutions, Axcellerate Pharma LLC, Labyrinth Biopharma LLC, Berkshire Sterile Manufacturing, PCI Pharma Services, Curia Global Inc, Emergent BioSolutions Inc., Jubilant HollisterStier LLC, Biofortuna, Lyophilization Technology Inc., and SYNERLAB GROUP are a few key companies operating in the lyophilization services for biopharmaceuticals market. These companies adopt product innovation strategies to meet evolving customer demands, which allows them to maintain their brand name. A few of the recent developments in the global lyophilization services for biopharmaceuticals market are mentioned below:

In May 2022, PCI Pharma Services (PCI), a leading global CDMO, announced a major expansion of capacity and capabilities in sterile lyophilization technology and aseptic liquid fill-finish, an important manufacturing process commonly used with injectable and biologic therapies, with the investment of US$ 100 million in the construction and enhancement of world-class facilities at its Bedford, New Hampshire campus. The facility will contain state-of-the-art technology, including an aseptic fill-finish line with a completely isolated containment system.

In November 2022, Lyophilization Technology, Inc. (LTI) successfully developed innovative technology to process lyophilized products in dual-chamber cartridges and syringes. The unique and novel aspects of the innovation provide processing for a wide variety of products. These products span small molecules, biologics such as proteins and vaccines.

In February 2022, Berkshire Sterile Manufacturing (BSM) announced the addition of formulation, lyophilization, and method development capabilities to complement their clients’ drug productions. BSM will offer first-in-human formulation development, supply material for preclinical studies, and conduct research-level stability studies. It will also offer formulation optimization, process development, process optimization, and scale-up studies.           

Directly Purchase Premium Copy of Lyophilization Services for Biopharmaceuticals Market Growth Report (2023-2028) at: https://www.theinsightpartners.com/buy/TIPRE00009286

Global Lyophilization Services for Biopharmaceuticals Market Share Report, Segmentations, Regional & Country Scope:

Browse key market insights spread across 156 pages with 57 list of tables & 67 list of figures from the report, "Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze Drying Analytical Services), and End User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others) " in detail along with the table of contents: https://www.theinsightpartners.com/reports/lyophilization-services-for-biopharmaceuticals-market

Impact of COVID-19 Pandemic on Lyophilization Services for Biopharmaceuticals Market.

Lyophilization is an effective technique that researchers are using as the scientific community aims to stabilize the SARS-CoV-2 virus vaccines, such as mRNA-LNP SARS-CoV-2 vaccines. According to an article published in the National Library of Medicine in April 2021, can, lyophilization is expected to be a logical step to improve the long-term stability of mRNA-LNP formulations. The head of Pfizer's viral vaccine research, Philip Dormitzer, has already mentioned Pfizer’s aspiration to use lyophilization for mRNA-LNP SARS-CoV-2 vaccxines. Moreover, a lyophilized form of an mRNA-based cytomegalovirus vaccine (mRNA-1647) is used in phase 2 clinical trials. It has a claimed shelf life of ≥ 18 months at 5 °C. Service providers in the lyophilization service for Biopharmaceuticals market experienced increased demand, mostly for researching and developing COVID-19 vaccines or therapeutics. Hence, the outbreak of COVID-19 has positively impacted the lyophilization service for Biopharmaceuticals market.

Rapid Increase in Contract Manufacturing and Lyophilization Services Fuels Lyophilization Services for Biopharmaceuticals Market Growth:   

The biopharmaceuticals market continues to expand across the world, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies are dependent on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed; in some cases, CMOs provide a great deal of a company’s production.

Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is an expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. Now, many biotechnology companies outsource various services, from early-stage drug development to commercial-scale manufacturing.

Speak to Analyst at https://www.theinsightpartners.com/speak-to-analyst/TIPRE00009286

As the biotechnology industry is shifting from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. One such CMO that provides specialized facilities and dedicated lines for lyophilization operations is Jubilant HollisterStier Contract Manufacturing & Services. The CMO offers sterile fill/finish of Phase I through a commercial sterile injectable and a full suite of lyophilization services. To keep up with the growing demand for its services, Jubilant is installing a new 385-square-foot lyophilizer. Thus, the rising capability and availability of biopharma CMOs fuel the lyophilization services for biopharmaceuticals market growth.

In pharmaceutical industries, lyophilization is widely used to increase the self-life of antibiotics, vaccines, and protein-based drugs. Biopharmaceutical companies are using lyophilization services to keep active pharmaceutical ingredients (APIs) and drugs sterile. Increasing good manufacturing practices are propelling the demand for lyophilization services.

Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):

Lyophilization Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis

Lyophilization/Freeze Drying Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis

Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis

Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis

Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com 

Phone: +1-646-491-9876

Press Release: https://www.theinsightpartners.com/pr/lyophilization-services-for-biopharmaceuticals-market